Association between hemoglobin A1c and all-causemortality: Results of the mortality follow-up of the German National Health Interview and Examination Survey 1998

Diabetes Care

Volumn 38, Issue 2, 2015, Pages 249-256

  Paprott, Rebecca ^a   Rosario, Angelika Schaffrath ^a   Busch, Markus A ^a   Du, Yong ^a   Thiele, Silke ^b   Scheidt Nave, Christa ^a   Heidemann, Christin ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; MORTALITY; RISK ASSESSMENT; SELF REPORT; ADOLESCENT; BLOOD; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; GERMANY; METABOLISM; MIDDLE AGED; PREDIABETIC STATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PREDIABETIC STATE; YOUNG ADULT;

EID: 84921907367     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-1787     Document Type: Article

References (38)

1. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM; American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2004;27(Suppl. 1):S91-S93
2. American Diabetes Association. Standards of medical care in diabetesd2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
4. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation. Geneva, World Health Organization, 2011
5. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
6. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
7. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004;141:413-420
8. Brewer N, Wright CS, Travier N, et al. A New Zealand linkage study examining the associations between A1C concentration and mortality. Diabetes Care 2008;31:1144-1149
9. Pfister R, Sharp SJ, Luben R, Khaw KT, Wareham NJ. No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population. Diabetologia 2011;54:2025-2032
10. Sakurai M, Saitoh S, Miura K, et al.; NIPPON DATA90 Research Group. HbA1c and the risks for all-cause and cardiovascular mortality in the general Japanese population: NIPPON DATA90. Diabetes Care 2013;36:3759-3765
11. Kowall B, Rathmann W, Heier M, et al. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol 2011;26:637-645
12. Chonchol M, Katz R, Fried LF, et al. Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metab Cardiovasc Dis 2010;20:15-21
13. Van't Riet E, Rijkelijkhuizen JM, Alssema M, et al. HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study. Eur J Prev Cardiol 2012;19:23-31
14. Saydah S, Tao M, Imperatore G, Gregg E. GHb level and subsequent mortality among adults in the U. S. Diabetes Care 2009;32:1440-1446
15. Aggarwal V, Schneider AL, Selvin E. Low hemoglobin A (1c) in nondiabetic adults: an elevated risk state? Diabetes Care 2012;35:2055-2060
16. Carson AP, Fox CS, McGuire DK, et al. Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes 2010;3:661-667
17. Levitan EB, Liu S, Stampfer MJ, et al. HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 2008;51:267-275
18. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009;52:415-424
19. Cohen BE, Barrett-Connor E, Wassel CL, Kanaya AM. Association of glucose measures with total and coronary heart disease mortality: does the effect change with time? The Rancho Bernardo Study. Diabetes Res Clin Pract 2009;86:67-73
20. Heidemann C, Scheidt-Nave C, Richter A, Mensink GB. Dietary patterns are associated with cardiometabolic risk factors in a representative study population of German adults. Br J Nutr 2011;106:1253-1262
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37(Suppl. 1):S81-S90
22. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
23. Brauns H, Scherer S, Steinmann S. The CASMIN educational classification in international comparative research. In Advances in Cross-National Comparison. Hoffmeyer-Zlotnik JH, Wolf C, Eds. New York, Kluwer, 2003, p. 221-244
24. Burger M, Mensink G, Brönstrup A, Thierfelder W, Pietrzik K. Alcohol consumption and its relation to cardiovascular risk factors in Germany. Eur J Clin Nutr 2004;58:605-614
25. World Health Organization. Nutritional Anaemias. Report of a WHO Scientific Group. Geneva, World Health Organization, 1968
26. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
27. Pani LN, Korenda L, Meigs JB, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the FraminghamOffspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008;31:1991-1996
28. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract 2010;87:415-421
29. Dailey G. Overall mortality in diabetes mellitus: where do we stand today? Diabetes Technol Ther 2011;13(Suppl. 1):S65-S74
30. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA (1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-489
31. Schöttker B, Müller H, Rothenbacher D, Brenner H. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia 2013;56:92-100
32. Christman AL, Lazo M, Clark JM, Selvin E. Low glycated hemoglobin and liver disease in the U. S. population. Diabetes Care 2011;34:2548-2550
33. Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 2012;50:635-641
34. Abril-Ulloa V, Flores-Mateo G, Solà-Alberich R, Manuel-y-Keenoy B, Arija V. Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies. BMC Public Health 2014;14:483
35. Lioudaki E, Ganotakis ES, Mikhailidis DP. Liver enzymes: potential cardiovascular risk markers? Curr Pharm Des 2011;17:3632-3643
36. Rutter MK. Low HbA1c and mortality: causation and confounding. Diabetologia 2012;55:2307-2311
37. Gao L, Matthews FE, Sargeant LA, Brayne C, Mrc C; MRC CFAS. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health 2008;8:54
38. Rohlfing C, Wiedmeyer HM, Little R, et al. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-1118